CitareTx Investment Partners

CitareTx Investment Partners is a venture capital firm established in 2008 and headquartered in Houston, Texas. The firm specializes in investing in companies within the medical technology sector, particularly those involved in healthcare devices, life sciences, health technology, and related fields. CitareTx focuses on identifying and nurturing innovative companies, primarily within Texas, that are positioned to advance healthcare solutions and improve patient outcomes. Through its investments, CitareTx aims to support the growth of transformative technologies in the healthcare landscape.

Timothy Schmidt

Venture Partner and Chief Commercialization Officer

Jeffery J. Sheldon

Co-Founder, General Partner and Managing Director

2 past transactions

Houston Medical Robotics

Series A in 2012
Houston Medical Robotics, Inc. is a Houston-based company founded in 2008 that specializes in the development and manufacture of innovative image-guided hand-held medical robotic devices for therapeutic applications. The company focuses on creating safer and more cost-effective procedural alternatives, aimed at enhancing caregiver efficiency and improving patient outcomes. Its advanced imaging technology facilitates the precise placement of central venous catheters and other vascular access procedures, thereby increasing the accuracy of surgical interventions and minimizing the risk of complications. Through its cutting-edge solutions, Houston Medical Robotics seeks to elevate the standards of care in medical practices while contributing to greater patient satisfaction and improved operational efficiency in healthcare settings.

EMIT

Series A in 2011
EMIT Corporation is a Houston-based company founded in 2009 that specializes in the design, development, manufacture, and sale of medical devices aimed at the treatment and prevention of hypothermia. The company’s flagship product, the HypothermX HX100, is a portable intravenous blood and fluid warming device that warms intravenous fluids, blood, and blood products. This technology is critical in addressing hypothermia arising from traumatic, environmental, and procedural causes, enabling healthcare providers in various settings, including medical, recreational, and military, to effectively manage and treat patients at risk of hypothermia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.